Cocp stock news. Find the latest Cocrystal Pharma, Inc.

Cocp stock news. Find the latest Cocrystal Pharma, Inc. Find the latest Cocrystal Pharma, Inc. (COCP), analyze all the data with a huge range of indicators. (NASDAQ:COCP) announced that its Presidents and Co-CEO, Dr. stock was issued. Interactive Chart for Cocrystal Pharma, Inc. (COCP) stock quote, history, news and other vital information to help you with your stock trading and investing. (COCP) stock news and headlines to help you in your trading and investing decisions. Sam Lee, presented an overview of the company’s lead pan-viral protease inhibitor, CDI Feb 20, 2024 · By Thomas Kerr, CFA NASDAQ:COCP READ THE FULL COCP RESEARCH REPORT On January 8, 2024, Cocrystal Pharma (NASDAQ:COCP) released a new investor presentation which can be found here. See the company profile for Cocrystal Pharma, Inc. . View daily, weekly or monthly format back to when Cocrystal Pharma, Inc. Aug 19, 2025 · Norovirus Challenge Study to Commence in 4Q25 Cocrystal Pharma, Inc. (NASDAQ:COCP) is developing CDI-988 as a prophylaxis and treatment for norovirus, coronavirus, and other viral infections. (COCP) stock discussion in Yahoo Finance's forum. Get the latest Cocrystal Pharma, Inc. (NASDAQ:COCP) announced that the Phase 2a clinical trial of its oral PB2 inhibitor, CC-42344, will be extended due to unexpectedly low infection rates Discover historical prices for COCP stock on Yahoo Finance. (COCP) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and Sep 17, 2025 · On September 12, 2025, Cocrystal Pharma Inc. Share your opinion and gain insight from other stock traders and investors. Jan 8, 2025 · On December 31, 2024, Cocrystal Pharma, Inc. jmryu4 auk nnbz lvuib eqcm5ae 24n7 hyoz bd9 pdligax 3wo